BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

PharmAthene, Inc. 

One Park Place
Suite 450
Annapolis  Maryland  21401  U.S.A.
Phone: 410-269-2600 Fax: 410-269-2601


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
PharmAthene, Inc. (PIP) Updates Status Of SparVax® Anthrax Vaccine Contract 4/8/2014 8:10:15 AM    More...
PharmAthene, Inc. (PIP) Updates Status Of SparVax® Anthrax Vaccine Contract 4/7/2014 3:20:11 PM    More...
PharmAthene, Inc. (PIP) Presents SparVax® Anthrax Vaccine Data At The New Technologies New Vaccines 2014 Conference 4/2/2014 6:23:18 AM    More...
PharmAthene, Inc. (PIP) Reports Year-End 2013 Financial And Operational Results 3/12/2014 6:41:17 AM    More...
PharmAthene, Inc. (PIP) Receives FDA Notification On SparVax® 12/16/2013 7:14:35 AM    More...
PharmAthene, Inc. (PIP) Terminates Merger Agreement With Theraclone Sciences, Inc. 12/2/2013 8:43:17 AM    More...
New PharmAthene, Inc. (PIP) SparVax® Anthrax Vaccine Data Published In Clinical and Vaccine Immunology 11/11/2013 10:15:34 AM    More...
PharmAthene, Inc. (PIP) Reports Third Quarter 2013 Financial and Operational Results 11/8/2013 7:10:49 AM    More...
PharmAthene, Inc. (PIP) Release: New Non-Clinical Data Confirm SparVax® Anthrax Vaccine Can Provide Protection Against Lethal Anthrax Challenge 9/13/2013 9:39:05 AM    More...
PharmAthene, Inc. (PIP) Files Registration Statement on Form S-4 With the Securities and Exchange Commission 9/9/2013 12:01:25 PM    More...
12345678910...

//-->